Inference Principles for Biostatisticians

1. Auflage 2020
ISBN: 978-0-367-57601-1
Verlag: Chapman and Hall/CRC

Buch, Englisch, 274 Seiten, Format (B × H): 156 mm x 234 mm, Gewicht: 424 g

Reihe: Chapman & Hall/CRC Biostatistics Series

Designed for students training to become biostatisticians as well as practicing biostatisticians, Inference Principles for Biostatisticians presents the theoretical and conceptual foundations of biostatistics. It covers the theoretical underpinnings essential to understanding subsequent core methodologies in the field.

Drawing on his extensive experience teaching graduate-level biostatistics courses and working in the pharmaceutical industry, the author explains the main principles of statistical inference with many examples and exercises. Extended examples illustrate key concepts in depth using a specific biostatistical context. In addition, the author uses simulation to reinforce the repeated sampling interpretation of numerous statistical concepts. Reducing the computational complexities, he provides simple R functions for conducting simulation studies.

This text gives graduate students with diverse backgrounds across the health, medical, social, and mathematical sciences a solid, unified foundation in the principles of statistical inference. This groundwork will lead students to develop a thorough understanding of biostatistical methodology.

Autoren/Hrsg.

Marschner, Ian C.

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizin, Gesundheitswesen Epidemiologie, Medizinische Statistik
• Mathematik | Informatik Mathematik Stochastik

Inhaltsverzeichnis

Probability and Random Samples. Estimation Concepts. Likelihood. Estimation Methods. Hypothesis Testing Concepts. Hypothesis Testing Methods. Bayesian Inference. Further Inference Topics. Appendices.

Über Autor(innen)

Ian C. Marschner is head of the Department of Statistics and a professor of statistics at Macquarie University. He is also a professor of biostatistics in the National Health and Medical Research Council (NHMRC) Clinical Trials Centre at the University of Sydney. He has over 25 years of experience as a biostatistician working on health and medical research, particularly involving clinical trials and epidemiological studies of cardiovascular disease, cancer, and HIV/AIDS. He was previously director of the Asia Biometrics Centre with Pfizer and an associate professor of biostatistics at Harvard University.